Compare TLS & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLS | RCEL |
|---|---|---|
| Founded | 1969 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.0M | 306.5M |
| IPO Year | 2020 | 2018 |
| Metric | TLS | RCEL |
|---|---|---|
| Price | $4.00 | $10.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $7.90 | $7.88 |
| AVG Volume (30 Days) | ★ 574.7K | 339.4K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.51 | 27.20 |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $164,805,000.00 | $71,610,000.00 |
| Revenue This Year | $18.72 | $17.17 |
| Revenue Next Year | $14.62 | $49.82 |
| P/E Ratio | $131.67 | ★ N/A |
| Revenue Growth | ★ 52.21 | 11.45 |
| 52 Week Low | $3.79 | $3.22 |
| 52 Week High | $8.36 | $11.39 |
| Indicator | TLS | RCEL |
|---|---|---|
| Relative Strength Index (RSI) | 34.63 | 59.50 |
| Support Level | $3.93 | $3.64 |
| Resistance Level | $4.67 | $10.77 |
| Average True Range (ATR) | 0.23 | 0.54 |
| MACD | -0.07 | -0.25 |
| Stochastic Oscillator | 1.18 | 20.67 |
Telos Corp offers technology solutions and services that empower and protect the world's security-conscious organizations. The company delivers efficient, adaptable, and secure solutions that protect people, organizations, and information across government and industry. The company conducts its business through two reportable and operating segments: Security Solutions and Secure Networks. The Security Solutions segment is focused on cybersecurity, cloud, and identity solutions, and secure messaging through Xacta, Telos AMHS, and Telos ID offerings. The Secure Networks segment provides secure networking architectures and solutions to customers through secure mobility solutions, network management, and defense services. The majority of revenue is from Secure Networks.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.